Literature DB >> 9857915

Smoking, lipoproteins and coronary heart disease risk. Data from the Münster Heart Study (PROCAM).

P Cullen1, H Schulte, G Assmann.   

Abstract

AIMS: The mechanism of the increase in coronary heart disease risk associated with smoking is unclear, but may partly be due to smoking-related changes in intermediate risk factors such as lipid levels, fibrinogen and blood pressure. We therefore examined the distribution of these variables among smokers and non-smokers in the Münster Heart Study.
METHODS: 20696 men, aged 41.7+/-2.7 years (mean +/- SD) and 10212 women, aged 37.0+/-2.6 years, were enrolled between 1978 and 1995. Thirty-two percent of women and 36% of men smoked. Compared to non-smokers, mean levels of low density lipoprotein cholesterol, total cholesterol, triglycerides and fibrinogen were increased, respectively, by 1.4%, 0.9%, 15% and 12.1% in male and by 2.0%, 5.5%, 12% and 3.4% in female smokers. Mean high density lipoprotein cholesterol levels, body mass index and blood pressure were reduced, respectively, by 6.4%, 3.8%, and 2% in male, and by 6.7% 1.2% and 2% in female smokers. In the subgroup of 4639 men aged 40 to 65 with 8 years of follow-up, the coronary event rate (definite myocardial infarction, sudden cardiac death) in cigarette smokers was more than twice that of non-smokers with otherwise identical risk factors.
CONCLUSION: In the Münster Heart Study, smoking was associated with adverse changes in lipids (of greater magnitude in women), and fibrinogen (of greater magnitude in men). However, these changes explained only a small part of the smoking-related increase in coronary heart disease risk.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9857915     DOI: 10.1053/euhj.1998.1086

Source DB:  PubMed          Journal:  Eur Heart J        ISSN: 0195-668X            Impact factor:   29.983


  12 in total

1.  Contribution of macromolecular structure to the retention of low-density lipoprotein at arterial branch points.

Authors:  Gina P Kwon; Jamie L Schroeder; Marcelo J Amar; Alan T Remaley; Robert S Balaban
Journal:  Circulation       Date:  2008-05-27       Impact factor: 29.690

Review 2.  Evolving concepts of the role of high-density lipoprotein in protection from atherosclerosis.

Authors:  John A Farmer; Joshua Liao
Journal:  Curr Atheroscler Rep       Date:  2011-04       Impact factor: 5.113

Review 3.  Abdominal obesity: the cholesterol of the 21st century?

Authors:  Jean-Pierre Després; Benoit J Arsenault; Mélanie Côté; Amélie Cartier; Isabelle Lemieux
Journal:  Can J Cardiol       Date:  2008-09       Impact factor: 5.223

4.  Smoking reduction, smoking cessation, and incidence of fatal and non-fatal myocardial infarction in Denmark 1976-1998: a pooled cohort study.

Authors:  N S Godtfredsen; M Osler; J Vestbo; I Andersen; E Prescott
Journal:  J Epidemiol Community Health       Date:  2003-06       Impact factor: 3.710

5.  Polymorphism in the cholesteryl ester transfer protein gene and the risk of early onset myocardial infarction among cigarette smokers.

Authors:  Ilan Goldenberg; Arthur J Moss; Robert Block; Daniel Ryan; James P Corsetti; Scott McNitt; Shirley W Eberly; Wojciech Zareba
Journal:  Ann Noninvasive Electrocardiol       Date:  2007-10       Impact factor: 1.468

6.  Dyslipidemia Management for Secondary Prevention in Women with Cardiovascular Disease: What Can We Expect From Non-pharmacologic Strategies?

Authors:  Seamus Whelton; Grant V Chow; Dominique Ashen; Roger S Blumenthal
Journal:  Curr Cardiovasc Risk Rep       Date:  2012-10

7.  The change in motivating factors influencing commencement, adherence and retention to a supervised resistance training programme in previously sedentary post-menopausal women: a prospective cohort study.

Authors:  Janet Erica Viljoen; Candice Jo-Anne Christie
Journal:  BMC Public Health       Date:  2015-03-12       Impact factor: 3.295

8.  Trends in prevalence of dyslipidaemias and the risk of mortality in Lithuanian urban population aged 45-64 in relation to the presence of the dyslipidaemias and the other cardiovascular risk factors.

Authors:  Dalia Luksiene; Abdonas Tamosiunas; Migle Baceviciene; Ricardas Radisauskas; Vilija Malinauskiene; Anne Peasey; Martin Bobak
Journal:  PLoS One       Date:  2014-06-23       Impact factor: 3.240

9.  Cigarette smoke increases cardiomyocyte ceramide accumulation and inhibits mitochondrial respiration.

Authors:  Trevor S Tippetts; Duane R Winden; Adam C Swensen; Michael B Nelson; Mikayla O Thatcher; Rex R Saito; Tyler B Condie; Kurtis J Simmons; Allan M Judd; Paul R Reynolds; Benjamin T Bikman
Journal:  BMC Cardiovasc Disord       Date:  2014-11-22       Impact factor: 2.298

10.  Significant association between functional microRNA polymorphisms and coronary heart disease susceptibility: a comprehensive meta-analysis involving 16484 subjects.

Authors:  Xu Liu; Lianghao You; Ruizhi Zhou; Jian Zhang
Journal:  Oncotarget       Date:  2017-01-24
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.